PubMed:7018927 JSONTXT

{"project":"TEST-DiseaseOrPhenotypicFeature","denotations":[{"id":"T1","span":{"begin":87,"end":105},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":493,"end":511},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"D006966"},{"id":"A2","pred":"#label","subj":"T2","obj":"D006966"}],"text":"Pituitary response to luteinizing hormone-releasing hormone during haloperidol-induced hyperprolactinemia.\nThe effects of a 6-hour infusion with haloperidol on serum prolactin and luteinizing hormone (LH) levels was studied in a group of male subjects. Five hours after starting the infusions, a study of the pituitary responses to LH-releasing hormone (LH-RH) was carried out. Control patients received infusions of 0.9% NaCl solution. During the course of haloperidol infusions, significant hyperprolactinemia was found, together with an abolished pituitary response to LH-RH, as compared with responses of control subjects."}

{"project":"TEST-ChemicalEntity","denotations":[{"id":"T1","span":{"begin":22,"end":41},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":67,"end":78},"obj":"ChemicalEntity"},{"id":"T4","span":{"begin":145,"end":156},"obj":"ChemicalEntity"},{"id":"T6","span":{"begin":166,"end":175},"obj":"ChemicalEntity"},{"id":"T7","span":{"begin":180,"end":199},"obj":"ChemicalEntity"},{"id":"T8","span":{"begin":201,"end":203},"obj":"ChemicalEntity"},{"id":"T9","span":{"begin":332,"end":352},"obj":"ChemicalEntity"},{"id":"T11","span":{"begin":354,"end":356},"obj":"ChemicalEntity"},{"id":"T12","span":{"begin":417,"end":426},"obj":"ChemicalEntity"},{"id":"T13","span":{"begin":427,"end":435},"obj":"ChemicalEntity"},{"id":"T15","span":{"begin":458,"end":469},"obj":"ChemicalEntity"},{"id":"T17","span":{"begin":572,"end":574},"obj":"ChemicalEntity"}],"attributes":[{"id":"A6","pred":"ID:","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_81580"},{"id":"A4","pred":"ID:","subj":"T4","obj":"D006220"},{"id":"A5","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_5613"},{"id":"A12","pred":"ID:","subj":"T12","obj":"D000077330"},{"id":"A13","pred":"ID:","subj":"T13","obj":"D012996"},{"id":"A14","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_75958"},{"id":"A2","pred":"ID:","subj":"T2","obj":"D006220"},{"id":"A3","pred":"ID:","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_5613"},{"id":"A17","pred":"ID:","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A15","pred":"ID:","subj":"T15","obj":"D006220"},{"id":"A16","pred":"ID:","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_5613"},{"id":"A8","pred":"ID:","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A7","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A9","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_5520"},{"id":"A11","pred":"ID:","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A1","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"}],"text":"Pituitary response to luteinizing hormone-releasing hormone during haloperidol-induced hyperprolactinemia.\nThe effects of a 6-hour infusion with haloperidol on serum prolactin and luteinizing hormone (LH) levels was studied in a group of male subjects. Five hours after starting the infusions, a study of the pituitary responses to LH-releasing hormone (LH-RH) was carried out. Control patients received infusions of 0.9% NaCl solution. During the course of haloperidol infusions, significant hyperprolactinemia was found, together with an abolished pituitary response to LH-RH, as compared with responses of control subjects."}

{"project":"TEST-OrganismTaxon","denotations":[{"id":"T1","span":{"begin":386,"end":394},"obj":"OrganismTaxon"}],"text":"Pituitary response to luteinizing hormone-releasing hormone during haloperidol-induced hyperprolactinemia.\nThe effects of a 6-hour infusion with haloperidol on serum prolactin and luteinizing hormone (LH) levels was studied in a group of male subjects. Five hours after starting the infusions, a study of the pituitary responses to LH-releasing hormone (LH-RH) was carried out. Control patients received infusions of 0.9% NaCl solution. During the course of haloperidol infusions, significant hyperprolactinemia was found, together with an abolished pituitary response to LH-RH, as compared with responses of control subjects."}

{"project":"Test-GeneOrGeneProduct","denotations":[{"id":"T1","span":{"begin":22,"end":59},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":166,"end":175},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":180,"end":199},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":201,"end":203},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":332,"end":334},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":354,"end":359},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":572,"end":577},"obj":"GeneOrGeneProduct"}],"text":"Pituitary response to luteinizing hormone-releasing hormone during haloperidol-induced hyperprolactinemia.\nThe effects of a 6-hour infusion with haloperidol on serum prolactin and luteinizing hormone (LH) levels was studied in a group of male subjects. Five hours after starting the infusions, a study of the pituitary responses to LH-releasing hormone (LH-RH) was carried out. Control patients received infusions of 0.9% NaCl solution. During the course of haloperidol infusions, significant hyperprolactinemia was found, together with an abolished pituitary response to LH-RH, as compared with responses of control subjects."}

{"project":"Test-merged","denotations":[{"id":"T2","span":{"begin":493,"end":511},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T1","span":{"begin":87,"end":105},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T9458","span":{"begin":386,"end":394},"obj":"OrganismTaxon"},{"id":"T8","span":{"begin":572,"end":577},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":354,"end":359},"obj":"GeneOrGeneProduct"},{"id":"T44746","span":{"begin":22,"end":59},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":458,"end":469},"obj":"ChemicalEntity"},{"id":"T13","span":{"begin":427,"end":435},"obj":"ChemicalEntity"},{"id":"T12","span":{"begin":417,"end":426},"obj":"ChemicalEntity"},{"id":"T9","span":{"begin":332,"end":352},"obj":"ChemicalEntity"},{"id":"T46552","span":{"begin":201,"end":203},"obj":"ChemicalEntity"},{"id":"T7","span":{"begin":180,"end":199},"obj":"ChemicalEntity"},{"id":"T13946","span":{"begin":166,"end":175},"obj":"ChemicalEntity"},{"id":"T50232","span":{"begin":145,"end":156},"obj":"ChemicalEntity"},{"id":"T78028","span":{"begin":67,"end":78},"obj":"ChemicalEntity"}],"attributes":[{"id":"A2","pred":"#label","subj":"T2","obj":"D006966"},{"id":"A9","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_5520"},{"id":"A8","pred":"ID:","subj":"T46552","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A1","pred":"#label","subj":"T1","obj":"D006966"},{"id":"A14","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_75958"},{"id":"A13","pred":"ID:","subj":"T13","obj":"D012996"},{"id":"A5","pred":"ID:","subj":"T50232","obj":"http://purl.obolibrary.org/obo/CHEBI_5613"},{"id":"A4","pred":"ID:","subj":"T50232","obj":"D006220"},{"id":"A16","pred":"ID:","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_5613"},{"id":"A15","pred":"ID:","subj":"T15","obj":"D006220"},{"id":"A6","pred":"ID:","subj":"T13946","obj":"http://purl.obolibrary.org/obo/CHEBI_81580"},{"id":"A12","pred":"ID:","subj":"T12","obj":"D000077330"},{"id":"A7","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A3","pred":"ID:","subj":"T78028","obj":"http://purl.obolibrary.org/obo/CHEBI_5613"},{"id":"A24690","pred":"ID:","subj":"T78028","obj":"D006220"}],"text":"Pituitary response to luteinizing hormone-releasing hormone during haloperidol-induced hyperprolactinemia.\nThe effects of a 6-hour infusion with haloperidol on serum prolactin and luteinizing hormone (LH) levels was studied in a group of male subjects. Five hours after starting the infusions, a study of the pituitary responses to LH-releasing hormone (LH-RH) was carried out. Control patients received infusions of 0.9% NaCl solution. During the course of haloperidol infusions, significant hyperprolactinemia was found, together with an abolished pituitary response to LH-RH, as compared with responses of control subjects."}

{"project":"Test-merged-2","denotations":[{"id":"T34526","span":{"begin":22,"end":41},"obj":"ChemicalEntity"},{"id":"T78028","span":{"begin":67,"end":78},"obj":"ChemicalEntity"},{"id":"T50232","span":{"begin":145,"end":156},"obj":"ChemicalEntity"},{"id":"T13946","span":{"begin":166,"end":175},"obj":"ChemicalEntity"},{"id":"T7","span":{"begin":180,"end":199},"obj":"ChemicalEntity"},{"id":"T46552","span":{"begin":201,"end":203},"obj":"ChemicalEntity"},{"id":"T9","span":{"begin":332,"end":352},"obj":"ChemicalEntity"},{"id":"T11","span":{"begin":354,"end":356},"obj":"ChemicalEntity"},{"id":"T12","span":{"begin":417,"end":426},"obj":"ChemicalEntity"},{"id":"T13","span":{"begin":427,"end":435},"obj":"ChemicalEntity"},{"id":"T15","span":{"begin":458,"end":469},"obj":"ChemicalEntity"},{"id":"T17","span":{"begin":572,"end":574},"obj":"ChemicalEntity"},{"id":"T44746","span":{"begin":22,"end":59},"obj":"GeneOrGeneProduct"},{"id":"T71599","span":{"begin":166,"end":175},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":180,"end":199},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":201,"end":203},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":332,"end":334},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":354,"end":359},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":572,"end":577},"obj":"GeneOrGeneProduct"},{"id":"T9458","span":{"begin":386,"end":394},"obj":"OrganismTaxon"},{"id":"T1","span":{"begin":87,"end":105},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":493,"end":511},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_5520"},{"id":"A6","pred":"ID:","subj":"T13946","obj":"http://purl.obolibrary.org/obo/CHEBI_81580"},{"id":"A8","pred":"ID:","subj":"T46552","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A15","pred":"ID:","subj":"T15","obj":"D006220"},{"id":"A16","pred":"ID:","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_5613"},{"id":"A24690","pred":"ID:","subj":"T78028","obj":"D006220"},{"id":"A3","pred":"ID:","subj":"T78028","obj":"http://purl.obolibrary.org/obo/CHEBI_5613"},{"id":"A7","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A2","pred":"#label","subj":"T2","obj":"D006966"},{"id":"A17","pred":"ID:","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A13","pred":"ID:","subj":"T13","obj":"D012996"},{"id":"A14","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_75958"},{"id":"A4","pred":"ID:","subj":"T50232","obj":"D006220"},{"id":"A5","pred":"ID:","subj":"T50232","obj":"http://purl.obolibrary.org/obo/CHEBI_5613"},{"id":"A59846","pred":"ID:","subj":"T34526","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"},{"id":"A12","pred":"ID:","subj":"T12","obj":"D000077330"},{"id":"A1","pred":"#label","subj":"T1","obj":"D006966"},{"id":"A11","pred":"ID:","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_81568"}],"text":"Pituitary response to luteinizing hormone-releasing hormone during haloperidol-induced hyperprolactinemia.\nThe effects of a 6-hour infusion with haloperidol on serum prolactin and luteinizing hormone (LH) levels was studied in a group of male subjects. Five hours after starting the infusions, a study of the pituitary responses to LH-releasing hormone (LH-RH) was carried out. Control patients received infusions of 0.9% NaCl solution. During the course of haloperidol infusions, significant hyperprolactinemia was found, together with an abolished pituitary response to LH-RH, as compared with responses of control subjects."}